Jerry Chapman is a GMP consultant with nearly 40 years of experience in the pharmaceutical industry. His experience includes numerous positions in development, manufacturing, and quality, at the plant, site, and corporate levels. He designed and implemented a comprehensive “GMP Intelligence” process at Eli Lilly and again as a consultant at a top-five animal health firm. Jerry served as Senior Editor at International Pharmaceutical Quality (IPQ) for six years, producing in-depth reports of interest to industry and regulators in the drug GMP/CMC space. He currently does independent consulting for the pharma and animal health industries, and serves as Editor In Chief for Xavier Health.